ATH alterity therapeutics limited

Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy, page-311

  1. 3,776 Posts.
    lightbulb Created with Sketch. 365
    completely agree, great statement coming out of this report, is iron was seen to be removed from areas affected in PD, and they both agreed that this drug is needed in diseases such as dementia and PD (watch Q&A section again, big nods from Prof. Claseen with Dr Stamler mentioned this
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.4¢
Change
0.000(0.00%)
Mkt cap ! $128.9M
Open High Low Value Volume
1.4¢ 1.4¢ 1.3¢ $188.8K 13.50M

Buyers (Bids)

No. Vol. Price($)
35 20724621 1.3¢
 

Sellers (Offers)

Price($) Vol. No.
1.4¢ 1182673 6
View Market Depth
Last trade - 16.10pm 31/07/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.